Cytokinetics reported $80.87M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Amgen AMGN:US $ 14842M 257M
Arca Biopharma ABIO:US $ 2.88M 1.35M
Bayer BAYN:GR € 28727M 801M
Biogen BIIB:US $ 4211.6M 864.4M
Brainstorm Cell Therapeutics BCLI:US $ 5.85M 2.21M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Cytokinetics CYTK:US $ 80.87M 19.1M
Eisai 4523:JP Y 280829M 2895M
Eli Lilly And LLY:US $ 13682M 1411.2M
Exelixis EXEL:US $ 269.51M 14.18M
Genocea Biosciences GNCA:US $ 14.7M 0.13M
Geron GERN:US $ 38.47M 1.46M
Halozyme Therapeutics HALO:US $ 113.15M 1.1M
Intra Cellular Therapies ITCI:US $ 49.9M 0.53M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Ligand Pharmaceuticals LGND:US $ 36.3M 16.2M
Novartis NOVN:VX SF 29880M 247M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M